1. Home
  2. TITN vs GLUE Comparison

TITN vs GLUE Comparison

Compare TITN & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TITN
  • GLUE
  • Stock Information
  • Founded
  • TITN 1980
  • GLUE 2019
  • Country
  • TITN United States
  • GLUE United States
  • Employees
  • TITN N/A
  • GLUE N/A
  • Industry
  • TITN Other Specialty Stores
  • GLUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • TITN Consumer Discretionary
  • GLUE Health Care
  • Exchange
  • TITN Nasdaq
  • GLUE Nasdaq
  • Market Cap
  • TITN 341.6M
  • GLUE 308.8M
  • IPO Year
  • TITN 2007
  • GLUE 2021
  • Fundamental
  • Price
  • TITN $19.47
  • GLUE $6.93
  • Analyst Decision
  • TITN Buy
  • GLUE Buy
  • Analyst Count
  • TITN 4
  • GLUE 2
  • Target Price
  • TITN $22.25
  • GLUE $13.50
  • AVG Volume (30 Days)
  • TITN 167.1K
  • GLUE 1.7M
  • Earning Date
  • TITN 08-28-2025
  • GLUE 11-06-2025
  • Dividend Yield
  • TITN N/A
  • GLUE N/A
  • EPS Growth
  • TITN N/A
  • GLUE N/A
  • EPS
  • TITN N/A
  • GLUE 0.29
  • Revenue
  • TITN $2,580,509,000.00
  • GLUE $177,986,000.00
  • Revenue This Year
  • TITN N/A
  • GLUE $83.76
  • Revenue Next Year
  • TITN $0.57
  • GLUE N/A
  • P/E Ratio
  • TITN N/A
  • GLUE $23.59
  • Revenue Growth
  • TITN N/A
  • GLUE 2990.57
  • 52 Week Low
  • TITN $12.50
  • GLUE $3.50
  • 52 Week High
  • TITN $23.41
  • GLUE $12.40
  • Technical
  • Relative Strength Index (RSI)
  • TITN 44.96
  • GLUE 80.03
  • Support Level
  • TITN $19.99
  • GLUE $4.80
  • Resistance Level
  • TITN $21.26
  • GLUE $5.15
  • Average True Range (ATR)
  • TITN 0.77
  • GLUE 0.28
  • MACD
  • TITN -0.13
  • GLUE 0.15
  • Stochastic Oscillator
  • TITN 22.51
  • GLUE 83.57

About TITN Titan Machinery Inc.

Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

Share on Social Networks: